The more trials they fund and successfully complete, the more attractive the treatment and the bigger any deal. Advancing the treatment on their own should improve the outcome.
"But middle finger up to the Chinese for smashing the share price down"
In all probability.
- Forums
- ASX - By Stock
- VLA
- Ann: $29.6m Equity Placement to Lepu Medical Group of China
Ann: $29.6m Equity Placement to Lepu Medical Group of China, page-21
-
- There are more pages in this discussion • 60 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)